Main Management ETF Advisors, LLC Krystal Biotech, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.06 Billion
- Q1 2025
A detailed history of Main Management ETF Advisors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 5,047 shares of KRYS stock, worth $696,082. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,047
Previous 3,560
41.77%
Holding current value
$696,082
Previous $558,000
63.08%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$544 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$390 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$377 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$169 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$132 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.54B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...